M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally.

Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.

PureHealth is the largest healthcare group in the Middle East, building a Global Network of Care and Cover that redefines healthcare accessibility and excellence. With 100+ hospitals, 300+ clinics, advanced diagnostic centers, health insurance solutions, pharmacies, health tech, procurement, and investments, we are ensuring world-class healthcare and comprehensive cover across every stage of life.

With groundbreaking innovations at the forefront, we are challenging lifespans and reimagining health spans, advancing the science of longevity to unlock time for humankind. From the United Arab Emirates to the world, we are shaping the future of healthcare so everyone can live healthier, longer and fuller lives.

Founded in 2007 by Dr. Shamsheer Vayalil, Burjeel Holdings is one of the leading private healthcare service providers the MENA region, providing the highest standard of healthcare delivery and patient management across a network of hospitals, medical centers, pharmacies, and other services. Burjeel Holdings is well on its way to becoming the leading voice on healthcare systems in emerging markets and beyond. The company's focus on highly complex, specialized, and personalized services puts it in a leadership position and has made it a point of referral for domestic and international patients. The company is poised to strengthen its operations further at home and abroad. With ambitious expansion plans, Burjeel Holdings is set to bring healthcare benefits and strategic value to new markets.

GSK is a science-led global healthcare company on a mission to research, develop, manufacture and market innovative medicines and vaccines to unite science, technology and talent to get ahead of disease together.

GSK has a 300-year global legacy, and for more than 65 years has been operating, employing and investing in the Gulf Cooperation Council region.

We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

 

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com. Follow us at @JNJNews and on LinkedIn.

 

We’re a medicine company turning science into healing to make life better for people around the world. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." But we’re not only dedicated to making medicines. We go beyond medicine to innovative clinical trials that reflect the diversity of our world and work to ensure our medicines are accessible and affordable.

Microsoft (Nasdaq “MSFT” @microsoft) creates platforms and tools powered by AI to deliver innovative solutions that meet the evolving needs of our customers. The technology company is committed to making AI available broadly and doing so responsibly, with a mission to empower every person and every organization on the planet to achieve more.

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.comand investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X (formerly Twitter).

 

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Our strategy is to deliver high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. Our purpose is to reimagine medicine to improve and extend people's lives and our vision to become the most valued and trusted medicines company in the world.

 

Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. In recognizing our endeavor to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work. In the Middle East, Roche offers comprehensive pharmaceutical and diagnostic expertise through the relevant and appropriate channels in 14 countries: Bahrain, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Maldives, Oman, Palestine, Qatar, Saudi Arabia, Syria, United Arab Emirates, and Yemen.

With over 175 years of experience, we have worked with leaders globally to build better futures, support their people, and achieve success, all while caring for our communities. Deloitte’s uninterrupted presence in the Middle East since 1926 has significantly contributed to the growth and advancement of the professional services industry in the region.

Our greatest minds continue to shape the future by delivering measurable results. We go beyond talk – we act. Deloitte is the world’s largest professional services firm, providing audit and assurance, tax, consulting, and related services to public and private clients across multiple industries. As a purpose-driven organisation, we are committed to leading the way in society and addressing some of the most complex societal challenges.

We serve clients distinctively, bringing innovative insights, solving complex challenges, and unlocking sustainable growth

 

We're entering 2025 with momentum and strength. As the long-standing leader in HIV, we’re committed to helping end the epidemic with the advancement of unprecedented long-acting medications for both HIV prevention and treatment. Our diversified pipeline has the potential to deliver best-in-class therapies to address multiple myeloma and other types of cancer, the rare liver disease primary biliary cholangitis, and other diseases across our therapeutic areas.

Juvenescence is a clinical-stage drug development company dedicated to extending healthy lifespan through developing novel medicines that target underlying causes of ageing.  

Juvenescence has pipeline of therapeutics in development led by a world class drug development team at the forefront of longevity science. Powered by an unrivalled R&D leadership, we leverage cutting-edge AI tools to identify and develop groundbreaking medicines.